Our team is led by recognized healthcare, cannabis regulatory and technology leaders/innovators.
Their focus is always on driving to (and measuring) the real-world outcomes that matter most to you - and to all who are working to help cannabis find its place as a responsibly provided, evidence-based medical treatment.
All the input and feedback you provide is securely analyzed by our proprietary data model which then generates draft care plans and insights for our clinicians to review, edit, add to and approve.
This allows them to provide care that’s more informed by more patients like you, spend less time on administrative tasks and more time with you.
Our recommended CBD and THC products are sourced from leading Massachusetts wholesale and delivery partners and must meet our clinical teams’ consistency and efficacy requirements.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
An internationally recognized cannabis clinician and educator, Dr Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
A longtime startup founder and investor in data-driven guidance platforms, Sean has focused for years on helping people and businesses make decisions in the context of uncertainty. He has deep expertise in digital/app-based startups, Bayesian and ML team formation, product commercialization and distribution.
A CX, design and marketing innovator, Dave co-founded, grew and sold two leading digital agencies (BEAM and Euro RSCG Circle). He has overseen product and experience design efforts for some of the largest and most disruptive consumer products, healthcare, financial services and automotive brands in the world.
Kristen is an innovative quantitative / algorithmic modeler with experience across medical, biotech and financial services industry verticals (Cinch, Signal Financial Technologies, Sermo, Thermo Fisher). She is expert in Bayesian, AI and decision network model design, prototyping and performance evaluation.
Ben is a board-certified family physician and internationally recognized cannabis clinician, educator, entrepreneur and advocate. He's the founder of CED Clinic Intl & CED Foundation. Trained at Tufts and BU, Ben also studied at the UCLA Brain Mapping Center. His papers have appeared in the NEJM among other publications.
A strategic social media marketer and researcher, Camila has successfully led grassroots audience growth and engagement efforts for several organizations. Her experience is in identifying new marketing opportunities, as well as creating and distributing dynamic content tailored to specific audiences and brands.
.png)
Formerly Chairman and CEO of Blue Cross Blue Shield of Massachusetts, Bill is a widely recognized healthcare industry leader and innovator. Currently, he is a lead director at Liberty Mutual and Eversource and a director at Acreage Holdings, where he also served as Interim CEO.
Most recently the Founding Chairman of the Massachusetts Cannabis Control Commission (CCC), Steve is a nationally-recognized cannabis regulatory leader and innovator. Previously, he served as CEO of two enterprise software companies and spent over a decade as a senior partner at Bain & Company.
.png)
With deep experience in health insurance, medical devices, mergers and acquisitions and cannabis investing, John brings a wealth of relevant expertise to the eo team. He is a past Head of Corporate Development at Aetna, served as CFO at Aptus Health and was an early investor in Sira Naturals, now part of AYR Wellness.
.png)
An experienced cannabis product business leader and innovator, Nial is expert in cannabis product definition and creation, IP, contracts and licensing, strategic planning/marketing, regulatory compliance and commercialization. He is the co-founder of Vella Bioscience and Manna Molecular.
An experienced employer healthcare benefits entrepreneur and leader, Brent founded and led corporate benefits workflow automation innovator Highroads, Inc. He was also previously director at Unata, Wright Rehab, and nHalience, a medical-grade cannabinoid inhaler and dosing platform.
Get special offers, event invites and the latest on new care offerings and product releases.
